tiprankstipranks
Trending News
More News >
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market

Seres Therapeutics (MCRB) Ratios

Compare
1,066 Followers

Seres Therapeutics Ratios

MCRB's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, MCRB's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.28 1.78 2.28 3.69 5.79
Quick Ratio
2.28 1.48 2.28 3.69 5.79
Cash Ratio
1.90 1.30 1.90 2.19 2.50
Solvency Ratio
-0.72 -0.27 -0.72 -0.23 -0.46
Operating Cash Flow Ratio
-2.67 -1.19 -2.67 0.08 -2.02
Short-Term Operating Cash Flow Coverage
-501.79 0.00 -501.79 1.01 -206.19
Net Current Asset Value
$ -143.24M$ -228.05M$ -143.24M$ 80.28M$ 100.59M
Leverage Ratios
Debt-to-Assets Ratio
0.47 0.60 0.47 0.14 0.12
Debt-to-Equity Ratio
15.08 -4.77 15.08 0.37 0.23
Debt-to-Capital Ratio
0.94 1.27 0.94 0.27 0.19
Long-Term Debt-to-Capital Ratio
0.82 1.79 0.82 0.16 0.12
Financial Leverage Ratio
32.35 -7.99 32.35 2.70 1.96
Debt Service Coverage Ratio
-37.24 -7.16 -37.24 -5.53 -22.10
Interest Coverage Ratio
-40.95 -8.20 -40.95 -22.16 -30.14
Debt to Market Cap
0.08 0.03 0.08 0.04 0.01
Interest Debt Per Share
1.56 1.77 1.56 0.57 0.55
Net Debt to EBITDA
<0.01 -0.91 <0.01 2.31 0.97
Profitability Margins
Gross Profit Margin
85.91%99.44%85.91%98.80%-172.68%
EBIT Margin
-3425.04%-79.59%-3425.04%-43.24%-259.53%
EBITDA Margin
-3332.04%-74.65%-3332.04%-39.14%-232.76%
Operating Profit Margin
-3458.05%-85.48%-3458.05%-44.50%-265.33%
Pretax Profit Margin
-3509.50%-90.02%-3509.50%-45.25%-268.33%
Net Profit Margin
-3560.94%-90.02%-3560.94%-42.43%-260.29%
Continuous Operations Profit Margin
-3509.50%-90.02%-3509.50%-45.25%-268.33%
Net Income Per EBT
101.47%100.00%101.47%93.78%97.00%
EBT Per EBIT
101.49%105.32%101.49%101.68%101.13%
Return on Assets (ROA)
-72.77%-31.71%-72.77%-17.33%-25.21%
Return on Equity (ROE)
-2353.93%253.53%-2353.93%-46.76%-49.47%
Return on Capital Employed (ROCE)
-93.66%-41.54%-93.66%-23.66%-29.72%
Return on Invested Capital (ROIC)
-93.59%-40.50%-93.59%-21.16%-28.30%
Return on Tangible Assets
-72.77%-31.71%-72.77%-17.33%-25.21%
Earnings Yield
-41.94%-3.17%-41.94%-8.05%-4.42%
Efficiency Ratios
Receivables Turnover
0.00 14.56 0.00 0.00 3.54
Payables Turnover
0.06 0.19 0.06 0.13 22.54
Inventory Turnover
0.00 0.02 0.00 0.00 90.57M
Fixed Asset Turnover
0.05 0.96 0.05 4.01 1.45
Asset Turnover
0.02 0.35 0.02 0.41 0.10
Working Capital Turnover Ratio
0.04 1.36 0.04 0.65 0.24
Cash Conversion Cycle
-6.34K 13.51K -6.34K -2.89K 86.96
Days of Sales Outstanding
0.00 25.06 0.00 0.00 103.15
Days of Inventory Outstanding
0.00 15.37K 0.00 0.00 <0.01
Days of Payables Outstanding
6.34K 1.89K 6.34K 2.89K 16.19
Operating Cycle
0.00 15.40K 0.00 0.00 103.15
Cash Flow Ratios
Operating Cash Flow Per Share
-2.12 -0.92 -2.12 0.07 -1.17
Free Cash Flow Per Share
-2.21 -0.98 -2.21 -0.03 -1.18
CapEx Per Share
0.09 0.06 0.09 0.10 <0.01
Free Cash Flow to Operating Cash Flow
1.04 1.07 1.04 -0.43 1.01
Dividend Paid and CapEx Coverage Ratio
-23.30 -14.72 -23.30 0.70 -158.39
Capital Expenditure Coverage Ratio
-23.30 -14.72 -23.30 0.70 -158.39
Operating Cash Flow Coverage Ratio
-1.41 -0.55 -1.41 0.14 -2.30
Operating Cash Flow to Sales Ratio
-32.10 -0.93 -32.10 0.05 -2.82
Free Cash Flow Yield
-39.43%-3.50%-39.43%-0.38%-4.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.38 -31.52 -2.38 -12.42 -22.61
Price-to-Sales (P/S) Ratio
84.91 28.37 84.91 5.27 58.85
Price-to-Book (P/B) Ratio
56.13 -79.90 56.13 5.81 11.19
Price-to-Free Cash Flow (P/FCF) Ratio
-2.54 -28.60 -2.54 -265.42 -20.75
Price-to-Operating Cash Flow Ratio
-2.65 -30.54 -2.65 114.22 -20.88
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.51 >-0.01 0.33 5.11
Price-to-Fair Value
56.13 -79.90 56.13 5.81 11.19
Enterprise Value Multiple
-2.55 -38.92 -2.55 -11.16 -24.31
Enterprise Value
604.79M 3.67B 604.79M 633.09M 1.88B
EV to EBITDA
-2.55 -38.92 -2.55 -11.16 -24.31
EV to Sales
84.85 29.05 84.85 4.37 56.59
EV to Free Cash Flow
-2.53 -29.28 -2.53 -219.98 -19.95
EV to Operating Cash Flow
-2.64 -31.27 -2.64 94.66 -20.08
Tangible Book Value Per Share
0.10 -0.35 0.10 1.43 2.19
Shareholders’ Equity Per Share
0.10 -0.35 0.10 1.43 2.19
Tax and Other Ratios
Effective Tax Rate
-0.01 0.00 -0.01 0.06 0.03
Revenue Per Share
0.07 0.99 0.07 1.58 0.42
Net Income Per Share
-2.35 -0.89 -2.35 -0.67 -1.08
Tax Burden
1.01 1.00 1.01 0.94 0.97
Interest Burden
1.02 1.13 1.02 1.05 1.03
Research & Development to Revenue
24.26 1.15 24.26 0.98 2.73
SG&A to Revenue
11.18 0.69 11.18 0.48 0.93
Stock-Based Compensation to Revenue
3.57 0.27 3.57 0.14 0.27
Income Quality
0.91 1.03 0.91 -0.10 1.05
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis